Prescribe With Confidence: Dexcom G7 Is Covered by More Provincial Programs and Private Insurers Than Ever Before
With coverage available through most provincial healthcare programs and private insurers,1 the Dexcom G7 Continuous Glucose Monitoring (CGM) System is now more accessible than ever for individuals living with diabetes on insulin.
As the most accurate CGM system in Canada,*,1 healthcare providers can feel confident prescribing Dexcom G7 — and in helping individuals self-manage their diabetes more effectively.
Dexcom G7 Coverage Has Recently Expanded in Ontario and Alberta
In Ontario, Dexcom G7 is now available as a benefit through the Assistive Devices Program (ADP). ADP is not income-dependent, and eligible residents can receive financial assistance for a real-time CGM system, increasing affordability for individuals living with type 1 diabetes (T1D). Individuals can apply for coverage through the Diabetes Education Program.
Similarly, Alberta has just expanded their coverage criteria and added Dexcom G7 as an eligible benefit. Individuals must be enrolled in an eligible government-sponsored health benefit plan† and meet the following criteria‡:
- Under 18 years of age: require the ongoing use of any insulin OR insulin pump therapy.
- 18 years of age and older: require the ongoing use of insulin pump therapy, OR a basal and bolus insulin, OR a premixed insulin.
Ontario and Alberta join an expansive list of provinces that now cover Dexcom G7, including: British Columbia, Manitoba, New Brunswick, Newfoundland & Labrador, Northwest Territories, Nova Scotia, Prince Edward Island, Quebec, Saskatchewan and Yukon.
For complete details for all provinces and provincial programs, visit our Provincial Coverage for Dexcom CGM page.
More Private Insurance Coverage for More People in 2024
Private insurers have also assisted in making Dexcom CGM technology more accessible than ever before. While coverage can vary according to the plan and policy, Dexcom G7 is covered by all major private insurers in Canada for plan members living with diabetes on insulin.§,1
This widespread availability reflects a growing recognition amongst private insurers of the importance of advanced diabetes management tools such as Dexcom CGM systems.
For complete details for all private insurers, visit our Employer-provided health plan coverage for Dexcom CGM page, or download a PDF private insurance guide.
Choose Dexcom CGM for Effective Diabetes Management
Dexcom G7 offers accurate, real-time glucose readings, helping individuals make informed decisions about their insulin use and overall health. The user-friendly interface and customizable alerts can help users stay engaged in their diabetes management.
Clinical studies have shown that real-time continuous glucose monitoring improves A1C and increases time in range (TIR),2-6 making it an effective tool for managing diabetes. With increasing provincial and private coverage across Canada, healthcare providers can confidently prescribe Dexcom G7 to individuals using insulin, knowing the device offers a proven solution that empowers their patients to manage their condition more effectively.
Provincial Coverage for Dexcom CGM
Private Insurance Coverage for Dexcom CGM
*When compared with CGM systems commercially available in Canada as of November 2023.
†To view a list of eligible government-sponsored health benefit plans, please visit https://idbl.ab.bluecross.ca/idbl/drugDetails?_cid=eef94732-04fd-42e1-8e66-68cfae3b60cb&id=0000111639&intchg_grp_nbr=1&detailId=12573683.
‡For detailed coverage criteria, please visit https://www.dexcom.com/en-ca/coverage/alberta-health-provincial-cgm-coverage.
§Eligibility varies by policy and plan. Prior Authorization of coverage may be required.
1 Dexcom, data on file, 2024.
2 Beck RW, et al. JAMA. 2017;317(4):371-378.
3 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
4 Martens T, et al. JAMA. 2021;325(22):2262-2272.
5 Laffel LM, et al. JAMA. 2020;323(23):2388-2396.
6 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7.